Kammann J, Dornbach G, Allmers R
Augenklinik, St. Johannes-Hospital Dortmund.
Ophthalmologe. 1994 Aug;91(4):442-5.
Fifty-four eyes with concomitant diseases, either a coagulation disorder or previous glaucoma surgery, were implanted with a folded, disc-shaped silicone intraocular lens (IOL) via a 3.5 mm three-step clear corneal tunnel; we developed this technique in 1991. IOLs of the same lens type were implanted through a 3.5 mm corneoscleral tunnel by the same surgeon in a control group consisting of 52 eyes. The final visual outcome was reached after 4 weeks in 44.7% of the patients (compared to 63.5% in the control group). The postoperative astigmatism stabilized after 3 months in 31.4% of the patients belonging to the clear corneal tunneling group and after 1 month in 32.1% of the patients belonging to the corneoscleral tunneling group. Compared to the control group, the continuously decreasing induced astigmatism was significantly greater in the clear corneal tunneling group at all times, except for 1 week postoperatively. After 1 year, the mean astigmatism was 0.91 +/- 0.50 D, compared to 0.57 +/- 0.36 D in the control group. After 18 months, the average induced astigmatism in the clear corneal tunneling group increased to 1.30 +/- 0.54 D, compared to the stable value in the control group amounting to 0.59 +/- 0.52 D. As an alternative to routine corneoscleral small incision surgery, the clear corneal technique is especially suited for patients with a coagulation disorder, with unfavorable anatomic conditions, or with glaucoma; a scleral incision should be avoided in these cases.
54只伴有凝血功能障碍或既往青光眼手术等合并症的眼睛,通过3.5毫米三步透明角膜隧道植入了折叠式盘状硅酮人工晶状体(IOL);我们于1991年开发了这项技术。在由52只眼睛组成的对照组中,同一位外科医生通过3.5毫米角巩膜隧道植入了相同类型的IOL。44.7%的患者在4周后达到最终视力结果(对照组为63.5%)。透明角膜隧道组31.4%的患者术后散光在3个月后稳定,角巩膜隧道组32.1%的患者在1个月后稳定。与对照组相比,除术后1周外,透明角膜隧道组在所有时间点诱导散光的持续下降均显著更大。1年后,平均散光为0.91±0.50 D,对照组为0.57±0.36 D。18个月后,透明角膜隧道组的平均诱导散光增加至1.30±0.54 D,而对照组的稳定值为0.59±0.52 D。作为常规角巩膜小切口手术的替代方法,透明角膜技术特别适合患有凝血功能障碍、解剖条件不佳或青光眼的患者;在这些情况下应避免巩膜切口。